요실금 관리 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 요실금 부위별, 최종 용도별, 백 용도별, 지역별, 부문별 예측(2025-2030년)

Continence Care Market Growth & Trends:

The global continence care market size is anticipated to reach USD 30.34 billion by 2030, with a CAGR of 7.49% from 2025 to 2030 according to a new report by Grand View Research, Inc. Increasing prevalence of various chronic disorders such as colorectal & bladder cancer, strokes, and diabetes. Growing technological advancements, increasing demand for sterile products in various healthcare and homecare settings, and changes in lifestyles, coupled with the rise in the geriatric population are key contributors to the market growth.

The rising prevalence of hypertension and diabetes is one of the major factors causing Urinary Incontinence (UI), driving the demand for continence care products globally. For instance, according to a report released by the WHO in 2023, approximately 1.28 billion people suffer from hypertension globally. Consequently, the increasing number of patients suffering from associated diseases is expected to surge the demand for continence care products.

Some of the companies operating in the U.S. continence care industry are Coloplast, Hollister Incorporated, and Convatec Group, among others. These companies offer a wide range of products & consumables and compete based on factors such as product quality, pricing, innovation, & distribution networks.

Continence Care Market Report Highlights:

• Based on product, the incontinence and bowel management held the largest market share of around 50.27% in 2024. Products such as male external catheters, female incontinence devices, and transanal irrigation systems are witnessing significant demand due to their effectiveness in managing these conditions.
• Based on application, the diabetes segment dominated the market in 2024 with a share of 27.94% owing to the globally increasing prevalence of diabetes and diabetes-associated UI.
• Based on bag usage, the sterile segment held the dominant market in 2024 and is expected to witness robust growth during the forecast period, as sterile bags are essential for avoiding infections and other problems.
• The home care settings segment held 44.68% of the overall end-user market in 2024, owing to an increase in demand for continence care products for home care and patient-centric healthcare services.
• Europe dominated the global market with the highest revenue share of 38.11% in 2024, owing to the high incidence rate of Crohn's disease & ulcerative colitis in this region. According to the Journal of Crohn's and Colitis, 0.3% of the total population in Europe suffers from IBD.

Table of Content

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Application
  • 1.2.3. Area of Incontinence
  • 1.2.4. Bag Usage
  • 1.2.5. End Use
  • 1.2.6. Regional Scope
  • 1.2.7. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Continence Care Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing prevalence of Urinary Incontinence (UI)
    • 3.2.1.2. Growing geriatric population
    • 3.2.1.3. Rapid technological advancements
    • 3.2.1.4. Rise in demand for minimally invasive procedures
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Growing concerns regarding Catheter-Associated Urinary Tract Infection (CAUTI)
• 3.3. Continence Care Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Continence Care Market: Segment Analysis, By Product, 2018 - 2030 (USD Million and Volume Unit)

• 4.1. Definition and Scope
• 4.2. Product Market Share Analysis, 2024 & 2030
• 4.3. Global Continence Care Market, by Product, 2018 to 2030
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
  • 4.4.1. Urinary Catheters
    • 4.4.1.1. Urinary Catheters market, 2018 - 2030 (USD Million and Volume Unit)
    • 4.4.1.2. Intermittent Self-Catheterization (ISC)
      • 4.4.1.2.1. Intermittent Self-Catheterization (ISC) market, 2018 - 2030 (USD Million and Volume Unit)
      • 4.4.1.2.2. Standard Catheters
        • 4.4.1.2.2.1. Standard Catheters market, 2018 - 2030 (USD Million and Volume Unit)
      • 4.4.1.2.3. Premium/Lifestyle Catheters
        • 4.4.1.2.3.1. Premium/Lifestyle Catheters market, 2018 - 2030 (USD Million and Volume Unit)
    • 4.4.1.3. Indwelling/Foley Catheters
      • 4.4.1.3.1. Indwelling/Foley Catheters market, 2018 - 2030 (USD Million and Volume Unit)
      • 4.4.1.3.2. Coated Catheters
        • 4.4.1.3.2.1. Coated Catheters market, 2018 - 2030 (USD Million and Volume Unit)
      • 4.4.1.3.3. Uncoated Catheters
        • 4.4.1.3.3.1. Uncoated Catheters market, 2018 - 2030 (USD Million and Volume Unit)
    • 4.4.1.4. Intermittent Catheter Sets
      • 4.4.1.4.1. Intermittent Catheter Sets market, 2018 - 2030 (USD Million and Volume Unit)
      • 4.4.1.4.2. Female
        • 4.4.1.4.2.1. Female market, 2018 - 2030 (USD Million and Volume Unit)
      • 4.4.1.4.3. Male
        • 4.4.1.4.3.1. Male market, 2018 - 2030 (USD Million and Volume Unit)
    • 4.4.1.5. Intermittent Catheters Dry
      • 4.4.1.5.1. Intermittent Catheters Dry market, 2018 - 2030 (USD Million and Volume Unit)
  • 4.4.2. Catheter Maintenance/Care
    • 4.4.2.1. Catheter Maintenance/Care market, 2018 - 2030 (USD Million and Volume Unit)
  • 4.4.3. Urinary Bags
    • 4.4.3.1. Urinary Bags market, 2018 - 2030 (USD Million and Volume Unit)
    • 4.4.3.2. Pediatric Urine Bags
      • 4.4.3.2.1. Pediatric Urine Bags market, 2018 - 2030 (USD Million and Volume Unit)
    • 4.4.3.3. Night (Bed) Bags
      • 4.4.3.3.1. Night (Bed) Bags market, 2018 - 2030 (USD Million and Volume Unit)
      • 4.4.3.3.2. By Usability
      • 4.4.3.3.3. Sterile
        • 4.4.3.3.3.1. Sterile market, 2018 - 2030 (USD Million and Volume Unit)
      • 4.4.3.3.4. Non-sterile
        • 4.4.3.3.4.1. Non-sterile market, 2018 - 2030 (USD Million and Volume Unit)
      • 4.4.3.3.5. By Usability
      • 4.4.3.3.6. Sterile
        • 4.4.3.3.6.1. Sterile market, 2018 - 2030 (USD Million and Volume Unit)
      • 4.4.3.3.7. Non-sterile
        • 4.4.3.3.7.1. Non-sterile market, 2018 - 2030 (USD Million and Volume Unit)
      • 4.4.3.3.8. By Size
      • 4.4.3.3.9. 250 ml
        • 4.4.3.3.9.1. 250 ml market, 2018 - 2030 (USD Million and Volume Unit)
      • 4.4.3.3.10. 350 ml
        • 4.4.3.3.10.1. 350 ml market, 2018 - 2030 (USD Million and Volume Unit)
      • 4.4.3.3.11. 500 ml
        • 4.4.3.3.11.1. 500 ml market, 2018 - 2030 (USD Million and Volume Unit)
      • 4.4.3.3.12. 1.5 L
        • 4.4.3.3.12.1. 1.5 L market, 2018 - 2030 (USD Million and Volume Unit)
      • 4.4.3.3.13. 2 L
        • 4.4.3.3.13.1. 2 L market, 2018 - 2030 (USD Million and Volume Unit)
      • 4.4.3.3.14. 4 L
        • 4.4.3.3.14.1. 4 L market, 2018 - 2030 (USD Million and Volume Unit)
      • 4.4.3.3.15. Others
        • 4.4.3.3.15.1. Others market, 2018 - 2030 (USD Million and Volume Unit)
    • 4.4.3.4. Bag Accessories
      • 4.4.3.4.1. Bag Accessories market, 2018 - 2030 (USD Million and Volume Unit)
    • 4.4.3.5. Leg Urine Bags
      • 4.4.3.5.1. Leg Urine Bags market, 2018 - 2030 (USD Million and Volume Unit)
      • 4.4.3.5.2. By Usability
      • 4.4.3.5.3. Sterile
        • 4.4.3.5.3.1. Sterile market, 2018 - 2030 (USD Million and Volume Unit)
      • 4.4.3.5.4. Non-sterile
        • 4.4.3.5.4.1. Non-sterile market, 2018 - 2030 (USD Million and Volume Unit)
      • 4.4.3.5.5. By Size
      • 4.4.3.5.6. 350 ml
        • 4.4.3.5.6.1. 250 ml market, 2018 - 2030 (USD Million and Volume Unit)
      • 4.4.3.5.7. 750 ml
        • 4.4.3.5.7.1. 350 ml market, 2018 - 2030 (USD Million and Volume Unit)
      • 4.4.3.5.8. 500 ml
        • 4.4.3.5.8.1. 500 ml market, 2018 - 2030 (USD Million and Volume Unit)
      • 4.4.3.5.9. 1.5 L
        • 4.4.3.5.9.1. 1.5 L market, 2018 - 2030 (USD Million and Volume Unit)
      • 4.4.3.5.10. 2 L
        • 4.4.3.5.10.1. 2 L market, 2018 - 2030 (USD Million and Volume Unit)
      • 4.4.3.5.11. 4 L
        • 4.4.3.5.11.1. 4 L market, 2018 - 2030 (USD Million and Volume Unit)
      • 4.4.3.5.12. Others
        • 4.4.3.5.12.1. Others market, 2018 - 2030 (USD Million and Volume Unit)
  • 4.4.4. Incontinence And Bowel Management
    • 4.4.4.1. Incontinence And Bowel Management market, 2018 - 2030 (USD Million and Volume Unit)
    • 4.4.4.2. Non-Absorbent
      • 4.4.4.2.1. Non-Absorbent market, 2018 - 2030 (USD Million and Volume Unit)
      • 4.4.4.2.2. Male External Catheters Silicone
        • 4.4.4.2.2.1. Male External Catheters Silicone market, 2018 - 2030 (USD Million and Volume Unit)
      • 4.4.4.2.3. Female External Catheters
        • 4.4.4.2.3.1. Female External Catheters market, 2018 - 2030 (USD Million and Volume Unit)
      • 4.4.4.2.4. Female Incontinence Device
        • 4.4.4.2.4.1. Female Incontinence Device market, 2018 - 2030 (USD Million and Volume Unit)
      • 4.4.4.2.5. Irrigation Pump/Transanal Irrigation
        • 4.4.4.2.5.1. Irrigation Pump/Transanal Irrigation market, 2018 - 2030 (USD Million and Volume Unit)
    • 4.4.4.3. Absorbent
      • 4.4.4.3.1. Absorbent market, 2018 - 2030 (USD Million and Volume Unit)
      • 4.4.4.3.2. Underwear & Briefs
        • 4.4.4.3.2.1. Underwear & Briefs market, 2018 - 2030 (USD Million and Volume Unit)
      • 4.4.4.3.3. Pads/Diapers
        • 4.4.4.3.3.1. Pads/Diapers market, 2018 - 2030 (USD Million and Volume Unit)
        • 4.4.4.3.3.2. Female
          • 4.4.4.3.3.2.1. Female market, 2018 - 2030 (USD Million and Volume Unit)
        • 4.4.4.3.3.3. Male
          • 4.4.4.3.3.3.1. Male market, 2018 - 2030 (USD Million and Volume Unit)
      • 4.4.4.3.4. Others
        • 4.4.4.3.4.1. Others market, 2018 - 2030 (USD Million and Volume Unit)

Chapter 5. Continence Care Market: Segment Analysis, By Applications, 2018 - 2030 (USD Million)

• 5.1. Definition and Scope
• 5.2. Applications Market Share Analysis, 2024 & 2030
• 5.3. Global Continence Care Market, by Applications, 2018 to 2030
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
  • 5.4.1. Diabetes
    • 5.4.1.1. Diabetes market, 2018 - 2030 (USD Million)
  • 5.4.2. Strokes
    • 5.4.2.1. Strokes market, 2018 - 2030 (USD Million)
  • 5.4.3. BPH
    • 5.4.3.1. BPH market, 2018 - 2030 (USD Million)
  • 5.4.4. Alzheimer
    • 5.4.4.1. Alzheimer market, 2018 - 2030 (USD Million)
  • 5.4.5. Cerebral Palsy
    • 5.4.5.1. Cerebral Palsy market, 2018 - 2030 (USD Million)
  • 5.4.6. Parkinson
    • 5.4.6.1. Parkinson market, 2018 - 2030 (USD Million)
  • 5.4.7. Prostate Cancer
    • 5.4.7.1. Prostate Cancer market, 2018 - 2030 (USD Million)
  • 5.4.8. Spinal Cord Injury
    • 5.4.8.1. Spinal Cord Injury market, 2018 - 2030 (USD Million)
  • 5.4.9. Bladder Cancer
    • 5.4.9.1. Bladder Cancer market, 2018 - 2030 (USD Million)
  • 5.4.10. Ovarian Cancer
    • 5.4.10.1. Ovarian Cancer market, 2018 - 2030 (USD Million)
  • 5.4.11. Multiple Sclerosis
    • 5.4.11.1. Multiple Sclerosis market, 2018 - 2030 (USD Million)
  • 5.4.12. Spina Bifida
    • 5.4.12.1. Spina Bifida market, 2018 - 2030 (USD Million)
  • 5.4.13. Others
    • 5.4.13.1. Others market, 2018 - 2030 (USD Million)

Chapter 6. Continence Care Market: Segment Analysis, By Area of Incontinence, 2018 - 2030 (USD Million)

• 6.1. Definition and Scope
• 6.2. Area of Incontinence Market Share Analysis, 2024 & 2030
• 6.3. Global Continence Care Market, by Area of Incontinence, 2018 to 2030
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
  • 6.4.1. Male
    • 6.4.1.1. Male market, 2018 - 2030 (USD Million)
    • 6.4.1.2. Stress Urinary Incontinence
      • 6.4.1.2.1. Stress Urinary Incontinence market, 2018 - 2030 (USD Million and Volume Unit)
    • 6.4.1.3. Urge/OAB (Overactive Bladder)
      • 6.4.1.3.1. Urge/OAB (Overactive Bladder) market, 2018 - 2030 (USD Million and Volume Unit)
    • 6.4.1.4. Overflow
      • 6.4.1.4.1. Overflow market, 2018 - 2030 (USD Million and Volume Unit)
    • 6.4.1.5. Functional
      • 6.4.1.5.1. Functional market, 2018 - 2030 (USD Million and Volume Unit)
    • 6.4.1.6. Mixed
      • 6.4.1.6.1. Mixed market, 2018 - 2030 (USD Million and Volume Unit)
    • 6.4.1.7. Reflex
      • 6.4.1.7.1. Reflex market, 2018 - 2030 (USD Million and Volume Unit)
    • 6.4.1.8. Severe Incontinence
      • 6.4.1.8.1. Severe Incontinence market, 2018 - 2030 (USD Million and Volume Unit)
  • 6.4.2. Female
    • 6.4.2.1. Female market, 2018 - 2030 (USD Million)
    • 6.4.2.2. Stress Urinary Incontinence
      • 6.4.2.2.1. Stress Urinary Incontinence market, 2018 - 2030 (USD Million and Volume Unit)
    • 6.4.2.3. Urge/OAB (Overactive Bladder)
      • 6.4.2.3.1. Urge/OAB (Overactive Bladder) market, 2018 - 2030 (USD Million and Volume Unit)
    • 6.4.2.4. Overflow
      • 6.4.2.4.1. Overflow market, 2018 - 2030 (USD Million and Volume Unit)
    • 6.4.2.5. Functional
      • 6.4.2.5.1. Functional market, 2018 - 2030 (USD Million and Volume Unit)
    • 6.4.2.6. Mixed
      • 6.4.2.6.1. Mixed market, 2018 - 2030 (USD Million and Volume Unit)
    • 6.4.2.7. Reflex
      • 6.4.2.7.1. Reflex market, 2018 - 2030 (USD Million and Volume Unit)
    • 6.4.2.8. Severe Incontinence
      • 6.4.2.8.1. Severe Incontinence market, 2018 - 2030 (USD Million and Volume Unit)

Chapter 7. Continence Care Market: Segment Analysis, By Bag Usage, 2018 - 2030 (USD Million)

• 7.1. Definition and Scope
• 7.2. Bag Usage Market Share Analysis, 2024 & 2030
• 7.3. Global Continence Care Market, by Bag Usage, 2018 to 2030
• 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
  • 7.4.1. Sterile Bags
    • 7.4.1.1. Sterile Bags market, 2018 - 2030 (USD Million)
  • 7.4.2. Non-sterile Bags
    • 7.4.2.1. Non-sterile Bags market, 2018 - 2030 (USD Million)

Chapter 8. Continence Care Market: Segment Analysis, By End Use, 2018 - 2030 (USD Million)

• 8.1. Definition and Scope
• 8.2. End Use Market Share Analysis, 2024 & 2030
• 8.3. Global Continence Care Market, by End Use, 2018 to 2030
• 8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
  • 8.4.1. Home Care
    • 8.4.1.1. Home Care market, 2018 - 2030 (USD Million)
    • 8.4.1.2. Rehabilitation Centers
      • 8.4.1.2.1. Rehabilitation Centers market, 2018 - 2030 (USD Million and Volume Unit)
    • 8.4.1.3. Nursing Homes
      • 8.4.1.3.1. Nursing Homes market, 2018 - 2030 (USD Million and Volume Unit)
    • 8.4.1.4. Others
      • 8.4.1.4.1. Others market, 2018 - 2030 (USD Million and Volume Unit)
  • 8.4.2. Hospitals
    • 8.4.2.1. Hospitals market, 2018 - 2030 (USD Million)
  • 8.4.3. Others
    • 8.4.3.1. Others market, 2018 - 2030 (USD Million)

Chapter 9. Continence Care Market: Regional Estimates & Trend Analysis

• 9.1. Regional Dashboard
• 9.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 9.3. North America
  • 9.3.1. U.S.
    • 9.3.1.1. Key country dynamics
    • 9.3.1.2. Regulatory framework/ reimbursement structure
    • 9.3.1.3. Competitive scenario
    • 9.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.3.2. Canada
    • 9.3.2.1. Key country dynamics
    • 9.3.2.2. Regulatory framework/ reimbursement structure
    • 9.3.2.3. Competitive scenario
    • 9.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
• 9.4. Europe
  • 9.4.1. UK
    • 9.4.1.1. Key country dynamics
    • 9.4.1.2. Regulatory framework/ reimbursement structure
    • 9.4.1.3. Competitive scenario
    • 9.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.2. Germany
    • 9.4.2.1. Key country dynamics
    • 9.4.2.2. Regulatory framework/ reimbursement structure
    • 9.4.2.3. Competitive scenario
    • 9.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.3. France
    • 9.4.3.1. Key country dynamics
    • 9.4.3.2. Regulatory framework/ reimbursement structure
    • 9.4.3.3. Competitive scenario
    • 9.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.4. Italy
    • 9.4.4.1. Key country dynamics
    • 9.4.4.2. Regulatory framework/ reimbursement structure
    • 9.4.4.3. Competitive scenario
    • 9.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.5. Spain
    • 9.4.5.1. Key country dynamics
    • 9.4.5.2. Regulatory framework/ reimbursement structure
    • 9.4.5.3. Competitive scenario
    • 9.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.6. Norway
    • 9.4.6.1. Key country dynamics
    • 9.4.6.2. Regulatory framework/ reimbursement structure
    • 9.4.6.3. Competitive scenario
    • 9.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.7. Sweden
    • 9.4.7.1. Key country dynamics
    • 9.4.7.2. Regulatory framework/ reimbursement structure
    • 9.4.7.3. Competitive scenario
    • 9.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.8. Denmark
    • 9.4.8.1. Key country dynamics
    • 9.4.8.2. Regulatory framework/ reimbursement structure
    • 9.4.8.3. Competitive scenario
    • 9.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.9. Belgium
    • 9.4.9.1. Key country dynamics
    • 9.4.9.2. Regulatory framework/ reimbursement structure
    • 9.4.9.3. Competitive scenario
    • 9.4.9.4. Belgium market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.10. Netherlands
    • 9.4.10.1. Key country dynamics
    • 9.4.10.2. Regulatory framework/ reimbursement structure
    • 9.4.10.3. Competitive scenario
    • 9.4.10.4. Netherlands market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.11. Ireland
    • 9.4.11.1. Key country dynamics
    • 9.4.11.2. Regulatory framework/ reimbursement structure
    • 9.4.11.3. Competitive scenario
    • 9.4.11.4. Ireland market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.12. Greece
    • 9.4.12.1. Key country dynamics
    • 9.4.12.2. Regulatory framework/ reimbursement structure
    • 9.4.12.3. Competitive scenario
    • 9.4.12.4. Greece market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.13. Poland
    • 9.4.13.1. Key country dynamics
    • 9.4.13.2. Regulatory framework/ reimbursement structure
    • 9.4.13.3. Competitive scenario
    • 9.4.13.4. Poland market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.14. Switzerland
    • 9.4.14.1. Key country dynamics
    • 9.4.14.2. Regulatory framework/ reimbursement structure
    • 9.4.14.3. Competitive scenario
    • 9.4.14.4. Switzerland market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.15. Austria
    • 9.4.15.1. Key country dynamics
    • 9.4.15.2. Regulatory framework/ reimbursement structure
    • 9.4.15.3. Competitive scenario
    • 9.4.15.4. Austriamarket estimates and forecasts 2018 to 2030 (USD Million)
• 9.5. Asia Pacific
  • 9.5.1. Japan
    • 9.5.1.1. Key country dynamics
    • 9.5.1.2. Regulatory framework/ reimbursement structure
    • 9.5.1.3. Competitive scenario
    • 9.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.2. China
    • 9.5.2.1. Key country dynamics
    • 9.5.2.2. Regulatory framework/ reimbursement structure
    • 9.5.2.3. Competitive scenario
    • 9.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.3. India
    • 9.5.3.1. Key country dynamics
    • 9.5.3.2. Regulatory framework/ reimbursement structure
    • 9.5.3.3. Competitive scenario
    • 9.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.4. Australia
    • 9.5.4.1. Key country dynamics
    • 9.5.4.2. Regulatory framework/ reimbursement structure
    • 9.5.4.3. Competitive scenario
    • 9.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.5. South Korea
    • 9.5.5.1. Key country dynamics
    • 9.5.5.2. Regulatory framework/ reimbursement structure
    • 9.5.5.3. Competitive scenario
    • 9.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.6. Thailand
    • 9.5.6.1. Key country dynamics
    • 9.5.6.2. Regulatory framework/ reimbursement structure
    • 9.5.6.3. Competitive scenario
    • 9.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 9.6. Latin America
  • 9.6.1. Brazil
    • 9.6.1.1. Key country dynamics
    • 9.6.1.2. Regulatory framework/ reimbursement structure
    • 9.6.1.3. Competitive scenario
    • 9.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.2. Mexico
    • 9.6.2.1. Key country dynamics
    • 9.6.2.2. Regulatory framework/ reimbursement structure
    • 9.6.2.3. Competitive scenario
    • 9.6.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.3. Argentina
    • 9.6.3.1. Key country dynamics
    • 9.6.3.2. Regulatory framework/ reimbursement structure
    • 9.6.3.3. Competitive scenario
    • 9.6.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.4. Colombia
    • 9.6.4.1. Key country dynamics
    • 9.6.4.2. Regulatory framework/ reimbursement structure
    • 9.6.4.3. Competitive scenario
    • 9.6.4.4. Colombia market estimates and forecasts 2018 to 2030 (USD Million)
• 9.7. MEA
  • 9.7.1. South Africa
    • 9.7.1.1. Key country dynamics
    • 9.7.1.2. Regulatory framework/ reimbursement structure
    • 9.7.1.3. Competitive scenario
    • 9.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.2. Saudi Arabia
    • 9.7.2.1. Key country dynamics
    • 9.7.2.2. Regulatory framework/ reimbursement structure
    • 9.7.2.3. Competitive scenario
    • 9.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.3. UAE
    • 9.7.3.1. Key country dynamics
    • 9.7.3.2. Regulatory framework/ reimbursement structure
    • 9.7.3.3. Competitive scenario
    • 9.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.4. Kuwait
    • 9.7.4.1. Key country dynamics
    • 9.7.4.2. Regulatory framework/ reimbursement structure
    • 9.7.4.3. Competitive scenario
    • 9.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Market Participant Categorization
• 10.2. Recent Developments & Impact Analysis by Key Market Participants
• 10.3. Company Market Share Analysis, 2024
• 10.4. Key Company Profiles
  • 10.4.1. Coloplast Group
    • 10.4.1.1. Company overview
    • 10.4.1.2. Financial performance
    • 10.4.1.3. Product benchmarking
    • 10.4.1.4. Strategic initiatives
  • 10.4.2. B. Braun SE
    • 10.4.2.1. Company overview
    • 10.4.2.2. Financial performance
    • 10.4.2.3. Product benchmarking
    • 10.4.2.4. Strategic initiatives
  • 10.4.3. Hollister Incorporated
    • 10.4.3.1. Company overview
    • 10.4.3.2. Financial performance
    • 10.4.3.3. Product benchmarking
    • 10.4.3.4. Strategic initiatives
  • 10.4.4. ConvaTec Group Plc
    • 10.4.4.1. Company overview
    • 10.4.4.2. Financial performance
    • 10.4.4.3. Product benchmarking
    • 10.4.4.4. Strategic initiatives
  • 10.4.5. BD (Becton, Dickinson and Company)
    • 10.4.5.1. Company overview
    • 10.4.5.2. Financial performance
    • 10.4.5.3. Product benchmarking
    • 10.4.5.4. Strategic initiatives
  • 10.4.6. Wellspect HealthCare
    • 10.4.6.1. Company overview
    • 10.4.6.2. Financial performance
    • 10.4.6.3. Product benchmarking
    • 10.4.6.4. Strategic initiatives
  • 10.4.7. Salts Healthcare Ltd.
    • 10.4.7.1. Company overview
    • 10.4.7.2. Financial performance
    • 10.4.7.3. Product benchmarking
    • 10.4.7.4. Strategic initiatives
  • 10.4.8. Welland Medical Ltd.
    • 10.4.8.1. Company overview
    • 10.4.8.2. Financial performance
    • 10.4.8.3. Product benchmarking
    • 10.4.8.4. Strategic initiatives
  • 10.4.9. Essity Aktiebolag
    • 10.4.9.1. Company overview
    • 10.4.9.2. Financial performance
    • 10.4.9.3. Product benchmarking
    • 10.4.9.4. Strategic initiatives